Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolus (EOLS) Change in Accured Expenses (2017 - 2026)

Evolus filings provide 9 years of Change in Accured Expenses readings, the most recent being -$3.7 million for Q1 2026.

  • On a quarterly basis, Change in Accured Expenses rose 73.58% to -$3.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $4.1 million, a 141.9% increase, with the full-year FY2025 number at -$6.4 million, down 191.2% from a year prior.
  • Change in Accured Expenses hit -$3.7 million in Q1 2026 for Evolus, down from $4.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $7.9 million in Q2 2024 to a low of -$14.2 million in Q1 2025.
  • Median Change in Accured Expenses over the past 5 years was $2.1 million (2023), compared with a mean of $40588.2.
  • Biggest five-year swings in Change in Accured Expenses: crashed 355.53% in 2022 and later skyrocketed 278.36% in 2024.
  • Evolus' Change in Accured Expenses stood at -$5.1 million in 2022, then surged by 239.52% to $7.1 million in 2023, then dropped by 17.73% to $5.8 million in 2024, then plummeted by 32.31% to $4.0 million in 2025, then tumbled by 194.69% to -$3.7 million in 2026.
  • The last three reported values for Change in Accured Expenses were -$3.7 million (Q1 2026), $4.0 million (Q4 2025), and $2.5 million (Q3 2025) per Business Quant data.